-
1
-
-
0034920207
-
MELD and PELD: Application of survival models to liver allocation
-
Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580.
-
(2001)
Liver Transpl
, vol.7
, pp. 567-580
-
-
Wiesner, R.H.1
McDiarmid, S.V.2
Kamath, P.S.3
Edwards, E.B.4
Malinchoc, M.5
Kremers, W.K.6
-
2
-
-
0037223652
-
For United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers
-
Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
-
(2003)
Gastroenterology
, vol.124
, pp. 91-96
-
-
Wiesner, R.1
Edwards, E.2
Freeman, R.3
Harper, A.4
Kim, R.5
Kamath, P.6
-
3
-
-
0242468963
-
MELD/PELD: One year later
-
Freeman RB Jr,. MELD/PELD: one year later. Transplant Proc 2003; 35: 2425-2427.
-
(2003)
Transplant Proc
, vol.35
, pp. 2425-2427
-
-
Freeman, Jr.R.B.1
-
4
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
-
5
-
-
2142717010
-
Liver transplantation for hepatocellular carcinoma: The MELD impact
-
Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10: 36-41.
-
(2004)
Liver Transpl
, vol.10
, pp. 36-41
-
-
Sharma, P.1
Balan, V.2
Hernandez, J.L.3
Harper, A.M.4
Edwards, E.B.5
Rodriguez-Luna, H.6
-
6
-
-
20444471977
-
Patient selection in an era of donor liver shortage: Current US policy
-
Wiesner RH,. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 24-30.
-
(2005)
Nat Clin Pract Gastroenterol Hepatol
, vol.2
, pp. 24-30
-
-
Wiesner, R.H.1
-
7
-
-
84879156652
-
Liver transplantation in the MELD era - Analysis of the OPTN/UNOS registry
-
Taniguchi M,. Liver transplantation in the MELD era-analysis of the OPTN/UNOS registry. Clin Transpl 2012: 41-65.
-
(2012)
Clin Transpl
, pp. 41-65
-
-
Taniguchi, M.1
-
8
-
-
33845940044
-
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: Impact on long-term survival
-
Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007; 245: 51-58.
-
(2007)
Ann Surg
, vol.245
, pp. 51-58
-
-
Poon, R.T.1
Fan, S.T.2
Lo, C.M.3
Liu, C.L.4
Wong, J.5
-
9
-
-
0035028451
-
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
-
Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
-
(2001)
Hepatology
, vol.33
, pp. 1080-1086
-
-
Jonas, S.1
Bechstein, W.O.2
Steinmüller, T.3
Herrmann, M.4
Radke, C.5
Berg, T.6
-
10
-
-
0031005298
-
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
-
Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485-1489.
-
(1997)
Hepatology
, vol.25
, pp. 1485-1489
-
-
Figueras, J.1
Jaurrieta, E.2
Valls, C.3
Benasco, C.4
Rafecas, A.5
Xiol, X.6
-
11
-
-
70349524972
-
Surgical dilemma: Liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria
-
Facciuto ME, Rochon C, Pandey M, Rodriguez-Davalos M, Samaniego S, Wolf DC, et al. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009; 11: 398-404.
-
(2009)
HPB (Oxford)
, vol.11
, pp. 398-404
-
-
Facciuto, M.E.1
Rochon, C.2
Pandey, M.3
Rodriguez-Davalos, M.4
Samaniego, S.5
Wolf, D.C.6
-
12
-
-
57049088162
-
Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area
-
Charpentier KP, Cheah YL, Machan JT, Miner T, Morrissey P, Monaco A,. Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area. HPB (Oxford) 2008; 10: 412-415.
-
(2008)
HPB (Oxford)
, vol.10
, pp. 412-415
-
-
Charpentier, K.P.1
Cheah, Y.L.2
Machan, J.T.3
Miner, T.4
Morrissey, P.5
Monaco, A.6
-
13
-
-
70450230745
-
A disease-based comparison of liver transplantation outcomes
-
Mailey B, Buchberg B, Prendergast C, Artinyan A, Khalili J, Sanchez-Luege N, et al. A disease-based comparison of liver transplantation outcomes. Am Surg 2009; 75: 901-908.
-
(2009)
Am Surg
, vol.75
, pp. 901-908
-
-
Mailey, B.1
Buchberg, B.2
Prendergast, C.3
Artinyan, A.4
Khalili, J.5
Sanchez-Luege, N.6
-
14
-
-
70449703365
-
Model for End Stage Liver Disease and hepatocellular carcinoma: A moving target
-
Washburn K,. Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target. Transplant Rev (Orlando) 2010; 24: 11-17.
-
(2010)
Transplant Rev (Orlando)
, vol.24
, pp. 11-17
-
-
Washburn, K.1
-
15
-
-
84859344179
-
Increasing disparity in waitlist mortality rates with increased Model for End-Stage Liver Disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma
-
Goldberg D, French B, Abt P, Feng S, Cameron AM,. Increasing disparity in waitlist mortality rates with increased Model for End-Stage Liver Disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl 2012; 18: 434-443.
-
(2012)
Liver Transpl
, vol.18
, pp. 434-443
-
-
Goldberg, D.1
French, B.2
Abt, P.3
Feng, S.4
Cameron, A.M.5
-
16
-
-
7044233345
-
Living donor liver transplantation for hepatocellular carcinoma
-
Kulik L, Abecassis M,. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127 (suppl 1): S277-S282.
-
(2004)
Gastroenterology
, vol.127
, Issue.SUPPL. 1
-
-
Kulik, L.1
Abecassis, M.2
-
17
-
-
34248634598
-
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
-
for A2ALL Study Group
-
Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al.; for A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601-1608.
-
(2007)
Am J Transplant
, vol.7
, pp. 1601-1608
-
-
Fisher, R.A.1
Kulik, L.M.2
Freise, C.E.3
Lok, A.S.4
Shearon, T.H.5
Brown Jr., R.S.6
-
18
-
-
71249088799
-
Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival
-
Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009; 15: 1861-1866.
-
(2009)
Liver Transpl
, vol.15
, pp. 1861-1866
-
-
Vakili, K.1
Pomposelli, J.J.2
Cheah, Y.L.3
Akoad, M.4
Lewis, W.D.5
Khettry, U.6
-
19
-
-
34248648185
-
Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma
-
Chao SD, Roberts JP, Farr M, Yao FY,. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant 2007; 7: 1594-1600.
-
(2007)
Am J Transplant
, vol.7
, pp. 1594-1600
-
-
Chao, S.D.1
Roberts, J.P.2
Farr, M.3
Yao, F.Y.4
-
20
-
-
84867574795
-
Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West
-
Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, et al. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol 2012; 57: 974-979.
-
(2012)
J Hepatol
, vol.57
, pp. 974-979
-
-
Lai, Q.1
Avolio, A.W.2
Lerut, J.3
Singh, G.4
Chan, S.C.5
Berloco, P.B.6
-
21
-
-
84889102306
-
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database
-
Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP,. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl 2013; 19: 1318-1323.
-
(2013)
Liver Transpl
, vol.19
, pp. 1318-1323
-
-
Samoylova, M.L.1
Dodge, J.L.2
Vittinghoff, E.3
Yao, F.Y.4
Roberts, J.P.5
-
22
-
-
33644747688
-
Characteristics associated with liver graft failure: The concept of a donor risk index
-
Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
-
(2006)
Am J Transplant
, vol.6
, pp. 783-790
-
-
Feng, S.1
Goodrich, N.P.2
Bragg-Gresham, J.L.3
Dykstra, D.M.4
Punch, J.D.5
Debroy, M.A.6
-
23
-
-
42949101344
-
Liver transplantation for hepatocellular carcinoma: Impact of the MELD allocation system and predictors of survival
-
Ioannou GN, Perkins JD, Carithers RL Jr,. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008; 134: 1342-1351.
-
(2008)
Gastroenterology
, vol.134
, pp. 1342-1351
-
-
Ioannou, G.N.1
Perkins, J.D.2
Carithers, Jr.R.L.3
-
24
-
-
79958055243
-
Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system
-
Washburn K, Edwards E, Harper A, Freeman R,. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010; 10: 1643-1648.
-
(2010)
Am J Transplant
, vol.10
, pp. 1643-1648
-
-
Washburn, K.1
Edwards, E.2
Harper, A.3
Freeman, R.4
-
25
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
26
-
-
0642303165
-
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
-
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA,. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817-823.
-
(2003)
Ann Intern Med
, vol.139
, pp. 817-823
-
-
El-Serag, H.B.1
Davila, J.A.2
Petersen, N.J.3
McGlynn, K.A.4
-
27
-
-
77955683595
-
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation
-
Roberts JP, Venook A, Kerlan R, Yao F,. Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl 2010; 16: 925-929.
-
(2010)
Liver Transpl
, vol.16
, pp. 925-929
-
-
Roberts, J.P.1
Venook, A.2
Kerlan, R.3
Yao, F.4
-
28
-
-
67649334063
-
Live-donor liver transplantation for hepatocellular carcinoma
-
Fan ST,. Live-donor liver transplantation for hepatocellular carcinoma. Hepatol Res 2007; 37 (suppl 2): S275-S276.
-
(2007)
Hepatol Res
, vol.37
, Issue.SUPPL. 2
-
-
Fan, S.T.1
-
29
-
-
84857571819
-
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: Comparable survival and recurrence
-
Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012; 18: 315-322.
-
(2012)
Liver Transpl
, vol.18
, pp. 315-322
-
-
Sandhu, L.1
Sandroussi, C.2
Guba, M.3
Selzner, M.4
Ghanekar, A.5
Cattral, M.S.6
-
30
-
-
4344652107
-
Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan
-
for Japanese Study Group on Organ Transplantation.
-
Todo S, Furukawa H,; for Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-459.
-
(2004)
Ann Surg
, vol.240
, pp. 451-459
-
-
Todo, S.1
Furukawa, H.2
-
31
-
-
84873095086
-
Living vs. Deceased donor liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis
-
Grant RC, Sandhu L, Dixon PR, Greig PD, Grant DR, McGilvray ID,. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant 2013; 27: 140-147.
-
(2013)
Clin Transplant
, vol.27
, pp. 140-147
-
-
Grant, R.C.1
Sandhu, L.2
Dixon, P.R.3
Greig, P.D.4
Grant, D.R.5
McGilvray, I.D.6
-
32
-
-
0842305761
-
Adult living donor liver transplantation for patients with hepatocellular carcinoma: Extending UNOS priority criteria
-
Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239: 142-149.
-
(2004)
Ann Surg
, vol.239
, pp. 142-149
-
-
Gondolesi, G.E.1
Roayaie, S.2
Muñoz, L.3
Kim-Schluger, L.4
Schiano, T.5
Fishbein, T.M.6
-
33
-
-
84884877663
-
Alpha-fetoprotein and modified Response Evaluation Criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation
-
for European Hepatocellular Cancer Liver Transplant Study Group
-
Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, et al.; for European Hepatocellular Cancer Liver Transplant Study Group. Alpha-fetoprotein and modified Response Evaluation Criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl 2013; 19: 1108-1118.
-
(2013)
Liver Transpl
, vol.19
, pp. 1108-1118
-
-
Lai, Q.1
Avolio, A.W.2
Graziadei, I.3
Otto, G.4
Rossi, M.5
Tisone, G.6
-
34
-
-
84888991921
-
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy
-
Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY,. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl 2013; 19: 1343-1353.
-
(2013)
Liver Transpl
, vol.19
, pp. 1343-1353
-
-
Mehta, N.1
Dodge, J.L.2
Goel, A.3
Roberts, J.P.4
Hirose, R.5
Yao, F.Y.6
-
35
-
-
84884874721
-
Moving past "one size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation
-
Mehta N, Yao FY,. Moving past "one size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation. Liver Transpl 2013; 19: 1055-1058.
-
(2013)
Liver Transpl
, vol.19
, pp. 1055-1058
-
-
Mehta, N.1
Yao, F.Y.2
-
36
-
-
80053287643
-
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
-
Yao FY, Breitenstein S, Broelsch CE, Dufour JF, Sherman M,. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver Transpl 2011; 17 (suppl 2): S109-S116.
-
(2011)
Liver Transpl
, vol.17
, Issue.SUPPL. 2
-
-
Yao, F.Y.1
Breitenstein, S.2
Broelsch, C.E.3
Dufour, J.F.4
Sherman, M.5
-
37
-
-
0038148323
-
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy
-
Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9: 684-692.
-
(2003)
Liver Transpl
, vol.9
, pp. 684-692
-
-
Yao, F.Y.1
Bass, N.M.2
Nikolai, B.3
Merriman, R.4
Davern, T.J.5
Kerlan, R.6
-
38
-
-
84864954136
-
Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma
-
Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA,. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant 2012; 26: E359-E364.
-
(2012)
Clin Transplant
, vol.26
-
-
Park, S.J.1
Freise, C.E.2
Hirose, R.3
Kerlan, R.K.4
Yao, F.Y.5
Roberts, J.P.6
Vagefi, P.A.7
-
39
-
-
1642399031
-
Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization
-
Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, Gores G,. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10: 449-455.
-
(2004)
Liver Transpl
, vol.10
, pp. 449-455
-
-
Maddala, Y.K.1
Stadheim, L.2
Andrews, J.C.3
Burgart, L.J.4
Rosen, C.B.5
Kremers, W.K.6
Gores, G.7
-
40
-
-
2442489095
-
Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation
-
Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M, et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 2004; 4: 782-787.
-
(2004)
Am J Transplant
, vol.4
, pp. 782-787
-
-
Hayashi, P.H.1
Ludkowski, M.2
Forman, L.M.3
Osgood, M.4
Johnson, S.5
Kugelmas, M.6
|